[go: up one dir, main page]

WO2001074994A3 - A novel peptide - human tnfr/nger protein 13 which contains cytochrome c structure domain and the polynucleotide coding this novelpeptide - Google Patents

A novel peptide - human tnfr/nger protein 13 which contains cytochrome c structure domain and the polynucleotide coding this novelpeptide Download PDF

Info

Publication number
WO2001074994A3
WO2001074994A3 PCT/CN2001/000220 CN0100220W WO0174994A3 WO 2001074994 A3 WO2001074994 A3 WO 2001074994A3 CN 0100220 W CN0100220 W CN 0100220W WO 0174994 A3 WO0174994 A3 WO 0174994A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptide
structure domain
disclosed
human tnfr
polynucleotide coding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000220
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001074994A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU44054/01A priority Critical patent/AU4405401A/en
Publication of WO2001074994A2 publication Critical patent/WO2001074994A2/en
Publication of WO2001074994A3 publication Critical patent/WO2001074994A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/80—Cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention disclosed a novel peptide - Human TNFR/NGFR protein13 which contains cytochrome C structure domain, polynucleotide coding this peptide and the method producing this peptide by DNA recombination techniques. This invention also disclosed the therapeutical methods with this peptide for several diseases, such as malignant tumour, haemal illness, HIV infection, Immunological illness and all kinds of inflammations, et al. This invention also disclosed an antagonist against this peptide and its therapical effect. The invention also disclosed the use of this polynucleotidecoding the novel human TNFR/NGFR protein 13 which contains cytochrome C structure domain.
PCT/CN2001/000220 2000-03-02 2001-02-26 A novel peptide - human tnfr/nger protein 13 which contains cytochrome c structure domain and the polynucleotide coding this novelpeptide Ceased WO2001074994A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU44054/01A AU4405401A (en) 2000-03-02 2001-02-26 A novel polypeptide, tnfr/nger protein 13 containing a cytochrome c domain and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00111879.X 2000-03-02
CN 00111879 CN1311254A (en) 2000-03-02 2000-03-02 New polypeptide-human TNFR/NGER protein 13 containing cytochrome C structure region and polynucleotide for coding such polypeptide

Publications (2)

Publication Number Publication Date
WO2001074994A2 WO2001074994A2 (en) 2001-10-11
WO2001074994A3 true WO2001074994A3 (en) 2002-03-21

Family

ID=4581775

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000220 Ceased WO2001074994A2 (en) 2000-03-02 2001-02-26 A novel peptide - human tnfr/nger protein 13 which contains cytochrome c structure domain and the polynucleotide coding this novelpeptide

Country Status (3)

Country Link
CN (1) CN1311254A (en)
AU (1) AU4405401A (en)
WO (1) WO2001074994A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250479A (en) * 1997-03-19 2000-04-12 依达研究发展有限公司 Modulators of the function of receptors of the TNF/NGF receptor family

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250479A (en) * 1997-03-19 2000-04-12 依达研究发展有限公司 Modulators of the function of receptors of the TNF/NGF receptor family

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 11 August 1999 (1999-08-11), KNIGHT T. ET AL., retrieved from GI:5726580 accession no. NCBI Database accession no. (AAD48475.1) *
DATABASE GENBANK [online] 19 July 1999 (1999-07-19), ROWEN L. ET AL., retrieved from GI:5524737 accession no. NCBI Database accession no. (AF111169.2) *

Also Published As

Publication number Publication date
AU4405401A (en) 2001-10-15
CN1311254A (en) 2001-09-05
WO2001074994A2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
EP2289550A3 (en) Ultra high affinity neutralizing antibodies
WO2001014424A3 (en) Human ctla-4 antibodies and their uses
WO2005002526A3 (en) Method and compositions for treatment of viral infections
WO2001090366A3 (en) Human polynucleotides and polypeptides encoded thereby
WO2004081199A3 (en) Novel compositions and methods for the treatment of immune related disease
WO2003055440A3 (en) Compositions and methods for the treatement of immune related diseases
WO2001074994A3 (en) A novel peptide - human tnfr/nger protein 13 which contains cytochrome c structure domain and the polynucleotide coding this novelpeptide
WO2003048317A3 (en) Antibodies to magmas and uses thereof
WO2002000829A3 (en) A novel peptide--- human ftsh protein 16.83 and the polynucleotide coding this novel peptide
WO2001075040A3 (en) A novel peptide human pterin molybdenum oxidation-reduction enzyme 12 and the polynucleotide coding this novel peptide
WO2002000830A3 (en) A novel peptide, phosphoenolpyruvate-dependant phosphotransferase 12 and the polynucleotide coding this novel peptide
WO2002070563A3 (en) Nuclear hormone receptor ligand binding domain
WO2002000832A3 (en) A novel polypeptide--a p80-coilin protein 8.8 and the polynucleotide encoding this novel polypeptide
WO2002000834A3 (en) A novel polypeptide--human protein phosphatase 9.68 and the polynucleotide
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
WO2001085903A3 (en) A novel polypeptide- human protein 9 which contains a p5cr characteristic sequence fragment and a polynucleotide encoding the same
WO2003070770A3 (en) Engineered human kunitz-type protease inhibitor
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
AU2002360062A1 (en) Tumour peptide antigen derived from the human cd19 protein
WO2002070560A3 (en) Nuclear hormone receptor ligand binding domain
WO2002034901A3 (en) Protein kinase
WO2001079431A3 (en) A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide
WO2001046243A3 (en) A new polypeptide-ring finger protein 8 and the polynucleotide encoding it
WO2001075006A3 (en) A novel poypeptide, light chain of protein lattice 37 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP